Though reduction of TET1 expression in most tumors was once considered a hallmark of cancer, recent studies have shown that high TET1 expression was associated with tumor grade and poor outcome in triple-negative breast cancer (TNBC) [30]. This evidence concerns the gene TET1 and cancer.